- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01739153
Effect of Cheese on Cardiovascular Risk (ECCA)
The main objective of the current study is to examine whether a high intake of regular-fat cheeses (Danbo and Cheddar) affect blood lipids differently than an isocaloric intake of either other fatty animal food products or of starchy carbohydrates. Furthermore, effects on fat digestibility, blood pressure, anthropometry, bile acid metabolism and insulin sensitivity is investigated.
To do this, a randomized crossover intervention study with 3x14 days full diet periods (cheese diet, meat diet or carb diet)will be conducted in 16 postmenopausal women. Between the diet periods there will be at least 14 days of wash-out where the subjects eat their habitual diets. Fasting blood samples will be drawn before and after the diet periods, and also a non-fasting blood sample will be drawn after the diet periods. Furthermore, total feces is collected the last 5 days of each diet period.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Frederiksberg
-
Copenhagen, Frederiksberg, Denmark, 1958
- Department of Nutrition, Exercise and Sports
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Female gender
- Postmenopausal for >1 year
- Age 45-68 years
- BMI 25-32 kg/m2
- TC > 4.5 mmol/L and < 7 mmol/L
- Systolic blood pressure <160 mmHg and/or diastolic blood pressure <100 mmHg
Exclusion Criteria:
- Chronic diseases (known diabetes; CVD; other chronic diseases which could affect the results of the present study)
- Milk allergy
- Nut allergy
- Use of dietary supplements incl. multivitamins (2 months before and during the entire study period)
- Smoking
- Elite athletes (>10 hours of strenuous physical activity per week)
- Use of prescription medicine which could affect the results of the present study including systemic glucocorticoids
- Use of lipid-lowering agents
- Stable dose of antihypertensive medication >3 months before study commencement for subjects with high blood pressure
- Hormone replacement therapy
- Blood donation <1 month before study commencement and during study period
- Simultaneous participation in other clinical studies
- Inability (physically or psychologically) to comply with the procedures required by the protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CARB diet
The CARB diet will be a low-fat diet where cheese is replaced by starchy carbohydrates and lean meat.
The CARB diet will have the same protein content (15 E%) and quality as the CHEESE and MEAT diet but a lower fat content (approx.
25 E%) and a correspondingly higher carbohydrate content (approx.
60 E%).
|
|
Experimental: CHEESE diet
The CHEESE diet will contain cheese in amounts corresponding to 120 g/day on a 10 MJ diet (approx.
1.8 MJ from cheese).
A high dose of cheese is chosen to provoke effects within this short time frame.
The cheese types used in this study will be Danbo (45+) and Cheddar (50+) which will be supplied in equal amounts.
The CHEESE diet will have the same macronutrient composition as that of the average Danish diet (15 E% from protein, max 35 E% from fat, and max 15 E% from saturated fat).
|
|
Experimental: MEAT diet
The MEAT diet will be a diet without dairy products.
In this diet cheese is mainly replaced by high-fat mixed meat products to achieve saturated fat content and protein quality similar to that of the CHEESE diet.
The MEAT diet will have the same macronutrient composition as that of the average Danish diet (15 E% from protein, max 35 E% from fat, and max 15 E% from saturated fat).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
LDL cholesterol
Time Frame: day 1 and day 14 in each diet period
|
fasting, mmol/l
|
day 1 and day 14 in each diet period
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Blood lipid concentrations
Time Frame: day 1 and day 14 in each diet period
|
Total cholesterol and HDL cholesterol. Fasting, mmol/l. Triglycerides. Fasting and non-fasting, mmol/l |
day 1 and day 14 in each diet period
|
ApoA1 and ApoB
Time Frame: day 1 and day 14 in each diet period
|
day 1 and day 14 in each diet period
|
|
Dietary fat digestibility
Time Frame: During day 10-14 in each period
|
Fecal fat and energy excretion. Total excretion of fecal fat (grams/day) and energy (kJ/day) averaged over five days |
During day 10-14 in each period
|
Blood pressure
Time Frame: day 1 and day 14 in each diet period
|
mmHg
|
day 1 and day 14 in each diet period
|
Anthropometry
Time Frame: day 1 and day 14 in each diet period
|
waist to hip ratio, waist circumference and body weight
|
day 1 and day 14 in each diet period
|
Insulin sensitivity
Time Frame: day 1 and 14 in each diet period
|
Fasting and non-fasting glucose and insulin
|
day 1 and 14 in each diet period
|
Bile acid metabolism
Time Frame: day 14 of each intervention period
|
Serum alpha-HC, fecal bile acid excretion
|
day 14 of each intervention period
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Arne Astrup, Prof, MD, Head of Department of Nutrition, Exercise and Sports
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- B302
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hyperlipidemia
-
Drug Commission of the German Medical AssociationMadaus AGTerminatedHypercholesterolemia | Combined Hyperlipidemia
-
Misr University for Science and TechnologyActive, not recruiting
-
DongKoo Bio & PharmaUnknownHyperlipidemia, HypertriglyceridemiaKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.CompletedHypercholesterolemia and HyperlipidemiaChina
-
Jeil Pharmaceutical Co., Ltd.CompletedHypertension With HyperlipidemiaKorea, Republic of
-
PfizerWithdrawnPrimary Hyperlipidemia or Mixed DyslipidemiaChina
-
ShionogiIntegriumCompletedCombined HyperlipidemiaUnited States
-
IlDong Pharmaceutical Co LtdCompletedHypertension With HyperlipidemiaKorea, Republic of
-
HK inno.N CorporationCompletedHypertension With Hyperlipidemia
-
LG Life SciencesCompletedHypertension, HyperlipidemiaKorea, Republic of
Clinical Trials on Dietary intervention: CARB (High Carbohydrate intake)
-
Medical University of BialystokMinistry of Science and Higher Education, PolandCompletedDiabetes Mellitus, Type 2 | Metabolic Syndrome | Diet Modification | Overweight and Obesity | Genetic PredispositionPoland
-
Hvidovre University HospitalDanish Diabetes AcademyCompletedHypoglycemia | Type 1 DiabetesDenmark
-
Anglia Ruskin UniversityUniversity of ExeterCompletedMuscle Soreness | Protein-energy; ImbalanceUnited Kingdom
-
Örebro University, SwedenCompletedDiabetes Mellitus, Type 1
-
University of California, San DiegoRecruiting
-
Liverpool John Moores UniversityCompletedEnergy Supply; Deficiency | Carbohydrate AvailabilityUnited Kingdom
-
National Center for Complementary and Integrative...Completed
-
Pennington Biomedical Research CenterCompleted
-
University of Sao PauloUnknownCancer | Surgery | Critically IllBrazil
-
Colorado State UniversityCompleted